Enlivex
Enlivex (Nasdaq: ENLV) converges clinical-stage longevity science with the high-convexity of the RAIN protocol.
Why it's on the radar
TeamFundraising signals (who's likely raising, and why) are on Team.Start a free 14-day trial →Funding history · 0 rounds
No rounds on record yet.
Key people
ProKey people, exec moves and open roles are on Pro.Start a free 14-day trial →